STERIS (STE) Projected to Post Quarterly Earnings on Wednesday

STERIS (NYSE:STE) will likely be issuing its quarterly earnings data after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $2.33 per share and revenue of $1.38 billion for the quarter. STERIS has set its FY25 guidance at $9.05-$9.25 EPS and its FY 2025 guidance at 9.050-9.250 EPS.Investors interested in listening to the company’s conference call can do so using this link.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 earnings per share for the quarter, beating the consensus estimate of $2.12 by $0.02. STERIS had a return on equity of 13.78% and a net margin of 8.02%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.33 billion. During the same period last year, the business earned $2.03 EPS. The business’s revenue was up 7.3% on a year-over-year basis. On average, analysts expect STERIS to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

STERIS Stock Down 0.4 %

STE opened at $220.84 on Monday. STERIS has a fifty-two week low of $197.82 and a fifty-two week high of $248.24. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 1.55. The company’s 50-day moving average is $212.15 and its 200 day moving average is $224.70. The firm has a market capitalization of $21.80 billion, a P/E ratio of 50.42 and a beta of 0.84.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be issued a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.03%. STERIS’s dividend payout ratio (DPR) is currently 52.05%.

Insider Transactions at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the firm’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $217.32, for a total value of $365,532.24. Following the sale, the senior vice president now owns 11,372 shares of the company’s stock, valued at $2,471,363.04. This trade represents a 12.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on STE shares. StockNews.com lowered STERIS from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 29th. Stephens reiterated an “overweight” rating and set a $260.00 target price on shares of STERIS in a research report on Thursday, November 7th. Piper Sandler raised shares of STERIS from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $230.00 to $260.00 in a research report on Thursday, October 24th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a report on Friday, November 8th. Finally, JMP Securities reissued a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Monday, November 18th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, STERIS currently has an average rating of “Moderate Buy” and an average price target of $262.50.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.